A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.

This publication has 13 references indexed in Scilit:

• An improved HPLC assay for monitoring phenylbutazone and its two major oxidised metabolites in plasma
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1980
• Clinical Pharmacokinetics of Phenylbutazone
  Clinical Pharmacokinetics, 1978
• BIOAVAILABILITY EVALUATION OF AN ENTERIC‐COATED PHENYLBUTAZONE FORMULATION, AND CROSS‐OVER COMPARISON WITH A SUGAR‐COATED PRODUCT
  The Medical Journal of Australia, 1977
• Plasma concentration of phenylbutazone and its therapeutic effect- studies in patients with rheumatoid arthritis.
  Published by Wiley ,1976
• Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.
  Published by Wiley ,1975
• The serum level approach to individualization of drug dosage
  European Journal of Clinical Pharmacology, 1975
• Individual Differences in the Plasma Half‐lives of Lipid Soluble Drugs in Man
  Acta Pharmacologica et Toxicologica, 1971
• Genetic Control of Drug Levels in Man: Phenylbutazone
  Science, 1968
• A study of structure-activity relationships in regard to species difference in the phenylbutazone series
  Biochemical Pharmacology, 1964
• PHENYLBUTAZONE THERAPY: RELATION BETWEEN THE TOXIC AND THERAPEUTIC EFFECTS AND THE BLOOD LEVEL
  The Lancet, 1954